Nanoxis AB, a biotechnology company is engaged in the development and commercialization of tools and methods for research on membrane proteins and drug discovery. The company`s LPI (Lipid based Protein Immobilization) technology enables to develop novel products and methodologies for the manipulation of membranes containing membrane bound components. Nanoxis offers a broad array services which includes membrane profiling, expression profiling, target identification, associated protein identification, protein subunit identification and relative quantification. The company has its operation spread across the Europe and Asia. It is headquartered in Gothenburg, Sweden.